Small-Audience Video Planning for Rare and Specialty Conditions

Planning video for small audiences requires different rules.

Start with the real audience size

For rare conditions, the number of diagnosed patients may be very small, and the number reachable through any partner smaller still. Resources such as the FDA's rare diseases information and published prevalence research help set realistic ranges. Plan with a low and high estimate, not a single number.

Decide who video is really for

With very small patient populations, video often works better aimed at broader groups:

• Specialists and care teams who treat the condition.
• Caregivers and families who research on behalf of patients.
• People with related symptoms who may not yet be diagnosed.

These groups are larger and may be where video can do more work. See rare-disease audience strategy.

Watch frequency closely

Small audiences hit frequency caps quickly. A modest video budget spread over a tiny audience can deliver dozens of exposures per person. Set strict caps, monitor the frequency distribution, and cut spend rather than letting frequency climb.

Set a minimum reportable cell

Reports broken down by region, specialty, or audience segment can produce cells with very few people. Small cells are statistically meaningless and can create privacy risk by making individuals identifiable. Set a minimum cell size below which results are not reported separately, and roll small groups into larger ones. Your privacy team and measurement partner should agree on the threshold.

Measurement expectations

Outcome studies in small audiences rarely have enough volume to detect modest effects. Be honest about this before launch. Options include:

• Measuring engagement and site actions rather than prescriptions.
• Using longer measurement periods to accumulate volume.
• Accepting directional evidence and saying so.

See measurement sensitivity analysis for testing how fragile small-sample results are.

Choose environments for precision

Broad CTV is hard to justify for a very small patient audience. More targeted options include HCP video in professional environments, contextual video on condition-specific content, and video within patient community sites where permitted.

Privacy considerations

Targeting very small health audiences increases the risk of revealing sensitive information. Review whether the use passes the fitness-for-use gate, and prefer contextual approaches where precision targeting could expose individuals.

Practical takeaway

Before planning rare-disease video, write down the realistic audience range, the minimum reportable cell size, the frequency cap, and what evidence you can realistically expect. If the audience is too small for video to do its job efficiently, move the budget to channels that can.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.